Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-22-000044
Filing Date
2022-08-09
Accepted
2022-08-08 18:13:08
Documents
97
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20220630x10q.htm   iXBRL 10-Q 2828746
2 EX-10.1 amph-20220630xex10d1.htm EX-10.1 491722
3 EX-31.1 amph-20220630xex31d1.htm EX-31.1 19165
4 EX-31.2 amph-20220630xex31d2.htm EX-31.2 18820
5 EX-32.1 amph-20220630xex32d1.htm EX-32.1 9833
6 EX-32.2 amph-20220630xex32d2.htm EX-32.2 9834
  Complete submission text file 0001297184-22-000044.txt   11830173

Data Files

Seq Description Document Type Size
7 EX-101.SCH amph-20220630.xsd EX-101.SCH 60897
8 EX-101.CAL amph-20220630_cal.xml EX-101.CAL 64789
9 EX-101.DEF amph-20220630_def.xml EX-101.DEF 282129
10 EX-101.LAB amph-20220630_lab.xml EX-101.LAB 476743
11 EX-101.PRE amph-20220630_pre.xml EX-101.PRE 450145
91 EXTRACTED XBRL INSTANCE DOCUMENT amph-20220630x10q_htm.xml XML 2421824
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 221145795
SIC: 2834 Pharmaceutical Preparations